First DIPG Cure Brings Hope for Pediatric Brain Cancer
A 13-year-old Belgian boy with DIPG became the first person in history to be cured of the fatal brain cancer after participating in the BIOMEDE trial, where everolimus eliminated his tumor with no recurrence to date; doctors suspect a rare genetic mutation made his tumor unusually responsive and plan to study organoids to replicate the results, while continuing exploration of therapies like immunotherapy—though this is not a universal cure and more research is needed.